IDXX Q1 2020 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$626M+8.7% YoY

Gross Profit

$360M57.4% margin

Operating Income

$144M23.0% margin

Net Income

$112M17.9% margin

EPS (Diluted)

$1.29

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

-$22M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$1.8B

Stockholders' Equity

$108M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$626M	$576M	+8.7%
Gross Profit	$360M	$332M	+8.4%
Operating Income	$144M	$133M	+8.4%
Net Income	$112M	$103M	+8.9%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$1.9B97%

Reagent Rental Programs

$29M1%

Extended Warranties And Post Contract Support

$23M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$397M63%

EMEA

$130M21%

Asia Pacific

$64M10%

CANADA

$24M4%

Latin America

$12M2%